AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 284: L187-L196, 2003; doi:10.1152/ajplung.00152.2002
1040-0605/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by John, T. A.
Right arrow Articles by Minshall, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by John, T. A.
Right arrow Articles by Minshall, R. D.
Vol. 284, Issue 1, L187-L196, January 2003

Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer

Theresa A. John1, Stephen M. Vogel1, Chinnaswamy Tiruppathi1, Asrar B. Malik1, and Richard D. Minshall1,2

Departments of 1 Pharmacology and 2 Anesthesiology, College of Medicine, University of Illinois, Chicago, Illinois 60612

We determined the concentration dependence of albumin binding, uptake, and transport in confluent monolayers of cultured rat lung microvascular endothelial cells (RLMVEC). Transport of 125I-albumin in RLMVEC monolayers occurred at a rate of 7.2 fmol · min-1 · 106 cells-1. Albumin transport was inhibited by cell surface depletion of the 60-kDa albumin-binding glycoprotein gp60 and by disruption of caveolae using methyl-beta -cyclodextrin. By contrast, gp60 activation (by means of gp60 cross-linking using primary and secondary antibodies) increased 125I-albumin uptake 2.3-fold. At 37°C, 125I-albumin uptake had a half time of 10 min and was competitively inhibited by unlabeled albumin (IC50 = 1 µM). Using a two-site model, we estimated by Scatchard analysis the affinity (KD) and maximal capacity (Bmax) of albumin uptake to be 0.87 µM (KD1) and 0.47 pmol/106 cells (Bmax1) and 93.3 µM (KD2) and 20.2 pmol/106 cells (Bmax2). At 4°C, we also observed two populations of specific binding sites, with high (KD1 = 13.5 nM, 1% of the total) and low (KD2 = 1.6 µM) affinity. On the basis of these data, we propose a model in which the two binding affinities represent the clustered and unclustered gp60 forms. The model predicts that fluid phase albumin in caveolae accounts for the bulk of albumin internalized and transported in the endothelial monolayer.

capillary permeability; vesicular transport; caveolae; albumin-binding glycoprotein gp60


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Tiruppathi, J. Shimizu, K. Miyawaki-Shimizu, S. M. Vogel, A. M. Bair, R. D. Minshall, D. Predescu, and A. B. Malik
Role of NF-{kappa}B-dependent Caveolin-1 Expression in the Mechanism of Increased Endothelial Permeability Induced by Lipopolysaccharide
J. Biol. Chem., February 15, 2008; 283(7): 4210 - 4218.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
E. G. Votta-Velis, R. D. Minshall, D. J. Visintine, M. Castellon, and I. V. Balyasnikova
Propofol Attenuates Endotoxin-Induced Endothelial Cell Injury, Angiotensin-Converting Enzyme Shedding, and Lung Edema
Anesth. Analg., November 1, 2007; 105(5): 1363 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. R. Infante, H. Matsubayashi, N. Sato, J. Tonascia, A. P. Klein, T. A. Riall, C. Yeo, C. Iacobuzio-Donahue, and M. Goggins
Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma
J. Clin. Oncol., January 20, 2007; 25(3): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. A. John, B. O. Ibe, and J. Usha Raj
Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1079 - L1093.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. R. Green, G. M. Manikhas, S. Orlov, B. Afanasyev, A. M. Makhson, P. Bhar, and M. J. Hawkins
Abraxane(R), a novel Cremophor(R)-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Ann. Onc., August 1, 2006; 17(8): 1263 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Yumoto, H. Nishikawa, M. Okamoto, H. Katayama, J. Nagai, and M. Takano
Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L946 - L955.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Desai, V. Trieu, Z. Yao, L. Louie, S. Ci, A. Yang, C. Tao, T. De, B. Beals, D. Dykes, et al.
Increased Antitumor Activity, Intratumor Paclitaxel Concentrations, and Endothelial Cell Transport of Cremophor-Free, Albumin-Bound Paclitaxel, ABI-007, Compared with Cremophor-Based Paclitaxel
Clin. Cancer Res., February 15, 2006; 12(4): 1317 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. W. Nyman, K. J. Campbell, E. Hersh, K. Long, K. Richardson, V. Trieu, N. Desai, M. J. Hawkins, and D. D. Von Hoff
Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies
J. Clin. Oncol., November 1, 2005; 23(31): 7785 - 7793.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, P. Bhar, M. Hawkins, and J. O'Shaughnessy
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil-Based Paclitaxel in Women With Breast Cancer
J. Clin. Oncol., November 1, 2005; 23(31): 7794 - 7803.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. K. Ibrahim, B. Samuels, R. Page, D. Doval, K. M. Patel, S.C. Rao, M. K. Nair, P. Bhar, N. Desai, and G. N. Hortobagyi
Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer
J. Clin. Oncol., September 1, 2005; 23(25): 6019 - 6026.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Mehta, J. Bhattacharya, M. A. Matthay, and A. B. Malik
Integrated control of lung fluid balance
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1081 - L1090.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Predescu, S. M. Vogel, and A. B. Malik
Functional and morphological studies of protein transcytosis in continuous endothelia
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L895 - L901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. C. Parker and M. I. Townsley
Evaluation of lung injury in rats and mice
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L231 - L246.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Minshall, W. C. Sessa, R. V. Stan, R. G. W. Anderson, and A. B. Malik
Caveolin regulation of endothelial function
Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1179 - L1183.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. L. TUMA and A. L. HUBBARD
Transcytosis: Crossing Cellular Barriers
Physiol Rev, July 1, 2003; 83(3): 871 - 932.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online